Sequana Medical 2021 H.C. Wainwright Global Investment Conference

Sequana Medical presented its innovative alfapump® system and DSR® therapy for treating diuretic-resistant fluid overload conditions including cirrhotic ascites, malignant ascites, and heart failure-related fluid accumulation. The presentation showcases the company's clinical pipeline and regulatory pathway toward addressing life-threatening fluid overload conditions across multiple therapeutic areas.